calcium carbonate + sodium alginate + sodium hydrogen carbonate: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
calcium carbonate + sodium alginate + sodium hydrogen carbonate: clinical details
Prescribing considerations
- Confirm symptoms are consistent with reflux; antacids can mask a more serious underlying disorder.
- Account for sodium burden in people requiring sodium restriction, including some with heart failure or renal impairment.
- Use additional caution with hypercalcaemia, nephrocalcinosis or recurrent calcium-containing renal calculi.
- Review concurrent oral medicines for absorption interactions.
- Check formulation-specific excipients, particularly aspartame, parabens, benzyl alcohol, sucrose and colouring agents.
- Products for children younger than 12 years should be used only on medical advice.
Contraindications and cautions
- Hypersensitivity to any active ingredient or formulation excipient
- Phenylketonuria for aspartame-containing tablets
- Severe renal impairment and hypophosphataemia for the selected mixed-berries chewable product
- Relevant hereditary fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency for sucrose-containing formulations
Monitoring
- Reassess persistent, recurrent or changing symptoms rather than continuing unsupervised treatment.
- Consider sodium, calcium and renal risks where clinically relevant.
- Investigate alarm symptoms or an atypical presentation.
Clinical pharmacology
Alginate reacts with gastric acid to create a floating, near-neutral gel raft that impedes gastro-oesophageal reflux. Calcium carbonate and sodium hydrogen carbonate neutralise acid. The principal anti-reflux effect is physical rather than dependent on systemic absorption.
Formulation and product differences
- Selected forms include bottled oral suspensions, liquid sachets and chewable tablets.
- Ingredient proportions and sodium and calcium content vary materially between products.
- Chewable tablets may contain aspartame; some mixed-berries tablets also contain sucrose and carmoisine.
- Some oral suspensions contain parahydroxybenzoates; the aniseed suspension also contains benzyl alcohol.
- One selected peppermint suspension is described as gluten- and sugar-free.
calcium carbonate + sodium alginate + sodium hydrogen carbonate interactions
The antacid ingredients can alter absorption of other oral medicines. Check suitable separation with a pharmacist, particularly for the following.
Tetracycline and fluoroquinolone antibiotics
Antacid binding can reduce antibiotic absorption.
Iron supplements
Absorption of oral iron may be reduced.
Levothyroxine and other thyroid hormones
Absorption may be reduced if taken too close together.
Bisphosphonates
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.